Simplex Trading, LLC Delcath Systems, Inc. Transaction History
Simplex Trading, LLC
- $175 Billion
- Q2 2025
A detailed history of Simplex Trading, LLC transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 6,505 shares of DCTH stock, worth $69,733. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,505
Previous 3,547
83.39%
Holding current value
$69,733
Previous $45,000
95.56%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding DCTH
# of Institutions
106Shares Held
12MCall Options Held
79KPut Options Held
53.3K-
Vanguard Group Inc Valley Forge, PA1.39MShares$14.9 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY813KShares$8.72 Million0.26% of portfolio
-
Vivo Capital, LLC Palo Alto, CA750KShares$8.04 Million2.59% of portfolio
-
Exodus Point Capital Management, LP New York, NY699KShares$7.5 Million0.09% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA557KShares$5.98 Million0.0% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $92.2M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...